MDMA will be approved for therapeutic use in the United States in 2022. New psychotherapy scenarios are expected to open, with new settings (for example, the use of a bed with the patient lying down and eyes closed, under the influence of "medical" MDMA, observed and followed by a couple of therapists trained in this regard). The primary objective of MDMA is to promote psychotherapy itself, interrupting (in theory) the patient's fear response reaction when he is dealing with traumatic memories.
Interview by Jonas Di Gregorio